文献速递小儿神经外科与脑积水神经重症

内镜下第三脑室造瘘术与脑室腹腔分流术治疗梗阻性脑积水的随机对照试验荟萃分析

Endoscopic Third Ventriculostomy versus Ventriculoperitoneal Shunt in Patients with Obstructive Hydrocephalus: Meta-Analysis of Randomized Controlled Trials.
PubMed 文献 · World Neurosurg · 2019-05-25

共纳入4项随机对照试验、250例患者,结果显示ETV组术后感染、术后血肿和堵塞率均显著低于VPS组,术后脑脊液漏和死亡率无显著差异。

要点

  • ETV组术后感染发生率显著低于VPS组(RR 0.09,95%CI 0.02-0.32,P=0.0002)。
  • ETV组术后血肿发生率显著低于VPS组(RR 0.26,95%CI 0.08-0.88,P=0.03)。
  • ETV组堵塞率显著低于VPS组(RR 0.28,95%CI 0.13-0.60,P=0.001)。

核心结论

  • 基于随机对照试验的荟萃分析,VPS手术的并发症发生率和死亡率更高,因此ETV可获得更大获益。

研究设计与样本

  • 从546项研究中纳入4项随机对照试验,共250例患者。

主要发现

  • ETV组术后感染发生率低于VPS组(RR 0.09,95%CI 0.02-0.32,P=0.0002)。
  • ETV组术后血肿发生率低于VPS组(RR 0.26,95%CI 0.08-0.88,P=0.03)。
  • ETV组堵塞率低于VPS组(RR 0.28,95%CI 0.13-0.60,P=0.001)。
  • ETV组与VPS组术后脑脊液漏发生率无显著差异(RR 2.00,95%CI 0.30-13.16,P=0.47)。
  • ETV组与VPS组死亡率无显著差异(RR 0.19,95%CI 0.03-1.09,P=0.06),但ETV组无死亡病例。

关键数值与推荐

  • ETV组术后感染风险为VPS组的0.09倍(RR 0.09,95%CI 0.02-0.32,P=0.0002)。
  • ETV组术后血肿风险为VPS组的0.26倍(RR 0.26,95%CI 0.08-0.88,P=0.03)。
  • ETV组堵塞风险为VPS组的0.28倍(RR 0.28,95%CI 0.13-0.60,P=0.001)。
  • ETV组与VPS组术后脑脊液漏风险无显著差异(RR 2.00,95%CI 0.30-13.16,P=0.47)。
  • ETV组与VPS组死亡风险无显著差异(RR 0.19,95%CI 0.03-1.09,P=0.06)。

临床怎么用

  • 对于梗阻性脑积水患者,ETV在降低术后感染、术后血肿和堵塞率方面优于VPS。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Endoscopic third ventriculostomy (ETV) and ventriculoperitoneal shunt (VPS) are 2 surgical methods used for the treatment of obstructive hydrocephalus. However, the efficacy and safety of these 2 procedures are unknown. Therefore we conducted a meta-analysis to compare the safety and efficiency of ETV and VPS in patients with obstructive hydrocephalus. METHODS: In January 2019, a comprehensive search strategy of 3 electronic databases was initiated. A systematic search from database inception to December 30, 2018, on clinical outcome, safety, and efficiency of ETV and VPS in the treatment of obstructive hydrocephalus was conducted. The following electronic databases were searched: PubMed, Embase, and Cochrane Library for related randomized controlled trials (RCTs). Main outcomes included postoperative hematoma, postoperative infection, postoperative cerebrospinal fluid leakage, blockage rate, and mortality. RESULTS: Of the 546 studies identified, 4 RCTs involving 250 patients met our inclusion criteria. The pooled results show that ETV was associated with lower incidence of postoperative infection (risk ratio [RR] 0.09, 95% confidence interval [CI]: 0.02-0.32, P = 0.0002); postoperative hematoma (RR 0.26, 95% CI: 0.08-0.88, P = 0.03); and blockage rate (RR 0.28, 95% CI: 0.13-0.60, P = 0.001) compared with VPS. Compared with VPS, ETV had no significant effect on incidence rate of postoperative cerebrospinal fluid leakage (RR 2.00, 95% CI: 0.30-13.16, P = 0.47) and mortality rates (RR 0.19, 95% CI: 0.03-1.09, P = 0.06), but there have been no deaths in patients treated with ETV. CONCLUSIONS: On the basis of the meta-analysis of RCTs evaluating ETV and VPS, the incidence of complications and mortality was higher with the VPS procedure, and therefore greater benefits can be achieved using ETV.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Lu L, Chen H, Weng S, et al. Endoscopic Third Ventriculostomy versus Ventriculoperitoneal Shunt in Patients with Obstructive Hydrocephalus: Meta-Analysis of Randomized Controlled Trials. World Neurosurg. 2019. PMID: 31136836. doi:10.1016/j.wneu.2019.04.255

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。